Get started
Author

Yutong Sui

Long non-coding RNA Irm enhances myogenic differentiation by interacting with MEF2D
2019 · Yutong Sui, Yu Han, et al. · Cell Death and Disease · 61
PDF
LncRNA MAGI2-AS3 is downregulated in non-small cell lung cancer and may be a sponge of miR-25
2020 · Yutong Sui, Wencheng Chi, et al. · BMC Pulmonary Medicine · 24
PDF
Identification of a natural compound, sesamin, as a novel TRPM8 antagonist with inhibitory effects on prostate adenocarcinoma
2020 · Yutong Sui, Shiyou Li, et al. · Fitoterapia · 23
Expression and Gene Regulation Network of Adenosine Receptor A2B in Lung Adenocarcinoma: A Potential Diagnostic and Prognostic Biomarker
2021 · Yutong Sui, Jiayin Liu, et al. · Frontiers in Molecular Biosciences · 21
PDF
Retracted: Effects of FOSL1 silencing on osteosarcoma cell proliferation, invasion and migration through the ERK/AP‐1 signaling pathway
2018 · Yu Han, Xingyu Zhao, et al. · Journal of Cellular Physiology · 21
PDF
Sesamin promotes apoptosis and pyroptosis via autophagy to enhance antitumour effects on murine T-cell lymphoma
2021 · Ziyu Meng, Hui Liu, et al. · Journal of Pharmacological Sciences · 20
PDF
Investigating the Multitarget Mechanism of Traditional Chinese Medicine Prescription for Cancer‐Related Pain by Using Network Pharmacology and Molecular Docking Approach
2020 · Jinyuan Chang, Lixing Liu, et al. · Evidence-based Complementary and Alternative Medicine · 17
PDF
Long non-coding RNA GClnc1 promotes tumorigenesis in osteosarcoma by inhibiting p53 signaling
2018 · Yutong Sui, Yu Han, et al. · Biochemical and Biophysical Research Communications · 16
Research Progress of Scutellaria baicalensis in the Treatment of Gastrointestinal Cancer
2024 · Lankang Wang, Baoyi Ni, et al. · Integrative Cancer Therapies · 12
Determining the mechanism of action of the Qishan formula against lung adenocarcinoma by integration of network pharmacology, molecular docking, and proteomics
2023 · Xue Geng, Wencheng Chi, et al. · Medicine · 5
A prospective diagnostic and prognostic biomarker for hepatocellular carcinoma that functions in glucose metabolism regulation: Solute carrier family 37 member 3
2023 · Ziyu Meng, Xue Geng, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 5
Evaluation of the Mechanism of Yishan Formula in Treating Breast Cancer Based on Network Pharmacology and Experimental Verification
2024 · Xiaoyue Lin, Wencheng Chi, et al. · Combinatorial Chemistry & High Throughput Screening · 2
Retracted: A Novel CircRNA Circ_0095424 Regulates Proliferation, Metastasis, and Apoptosis of Osteosarcoma Cells Via the PI3K/AKT Signaling Pathway Through Targeting the miR-1238 / HMGB1 Axis
2020 · Zhiguo Zhang, Yutong Sui, et al. · Cancer Biotherapy and Radiopharmaceuticals · 1
Uncovering the Q-marker and potential mechanisms of Qishan Formula for lung cancer based on multi-technology
2023 · Yutong Sui, Yanqun Yang, et al. · Journal of Liquid Chromatography & Related Technologies
Uncovering the Q-marker and potential mechanisms of Qishan Formula for lung cancer based on multi-technology
2023 · Sui, Yutong, Yang, Yanqun, et al. · Figshare
Works count: 16
Citation count: 230
H-index: 9
I10-index: 9
Year
Topic
Type